March 11, 2021
ARLINGTON, Va. — HDA President and CEO Chester “Chip” Davis, Jr., released the following statement in response to today’s enactment of The American Rescue Plan Act of 2021 by President Biden.
“As one of the industries helping to turn COVID-19 vaccines into vaccinations, providing enhanced support for a national vaccination program is critical as we look to turn the tide of this public health crisis. To that end, HDA and our healthcare distributors are pleased that this law includes significant funding for the Centers for Disease Control and Prevention to prepare, promote, distribute, administer, monitor and track COVID-19 vaccines; the Federal Emergency Management Agency to establish more vaccination sites around the country; as well as the Biomedical Advanced Research and Development Authority to support advanced research, development, manufacturing, production and purchase of vaccines, therapeutics and ancillary medical products for COVID-19.
“Further, the law provides $10 billion to increase the domestic production of personal protective equipment, secure supply chains, boost vaccine production and speed the manufacturing of rapid tests, which will help ensure much-needed products quickly make their way to providers and ultimately patients.
“In addition to fulfilling the daily healthcare needs of Americans, HDA’s healthcare distributor members are playing an integral role in COVID-19 response efforts, including the distribution of vaccines, medical supplies and novel treatments, and we are prepared to do more. As this law is implemented, our industry stands ready to assist in any way we can by leveraging our strong relationships at both ends of the healthcare supply chain — between 1,400 manufacturers and more than 180,000 providers — and coordinating closely with federal, state and local governments and other public healthcare stakeholders.”
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.